INGELHEIM, Germany–(BUSINESS WIRE)–In 2021, Boehringer Ingelheim again stepped up its annual investments in R&D to a new high in its 137-year history. The company spent 4.1 billion EUR on…
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
INGELHEIM, Germany–(BUSINESS WIRE)–In 2021, Boehringer Ingelheim again stepped up its annual investments in R&D to a new high in its 137-year history. The company spent 4.1 billion EUR on…